Greenwich LifeSciences Inc. (GLSI): Price and Financial Metrics Recent IPO


Greenwich LifeSciences Inc. (GLSI) Recent IPO

Today's Latest Price: $5.28 USD

0.21 (-3.83%)

Updated Nov 24 3:56pm

Add GLSI to Watchlist
Sign Up

Overall POWR Rating

Sign Up to See Ratings...FREE!

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

GLSI Stock Price Chart Interactive Chart >

Price chart for GLSI

GLSI Price/Volume Stats

Current price $5.28 52-week high $5.75
Prev. close $5.49 52-week low $3.26
Day low $5.13 Volume 33,400
Day high $5.47 Avg. volume 18,964
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap N/A

Greenwich LifeSciences Inc. (GLSI) Company Bio

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Most Popular Stories View All

• The 3 Best Stocks to Buy for December

• 2 Reasons Investors DON’T Care About Covid-19 Anymore

• 4 "Buy Rated" Clean Energy Stocks to Invest in for 2021

• Are Shares of CVS Still a Buy After the Launch of Amazon Pharmacy?

• 3 Stocks that Will Benefit as Bitcoin Skyrockets

View All Top Stories

GLSI Latest News Stream

Event/Time News Detail
Loading, please wait...
View All GLSI News

GLSI Latest Social Stream

Loading social stream, please wait...

View Full GLSI Social Stream

Latest GLSI News From Around the Web

Below are the latest news stories about Greenwich LifeSciences Inc that investors may wish to consider to help them evaluate GLSI as an investment opportunity.

Greenwich Lifesciences prices downsized IPO at $5.75

Breast cancer biotech, Greenwich Lifesciences (GLSI) has priced its downsized initial public offering of 1.26M (from 2.7M) shares at $5.75/share, for gross proceeds of $7.25M.IPO is priced at lower end of the revised range of $5.75-$6.75 and much below the original range of $7.50 to $8.50.Underwriters' over-allotment is an additional 189,130 shares.Trading...

Seeking Alpha | September 25, 2020

Greenwich Lifesciences launches 2.9M shares in IPO

Breast cancer biotech, Greenwich Lifesciences (GLSI) has launched initial public offering of 1.26M shares at an estimated price range of $5.75 - $6.75 per share. Selling stockholders to offer 1,685,394 shares.The company had previously filed to offer 2.7M shares at a range of $7.50 - $8.50.2019 Financials: Operating Expenses: $3.43M (+103%); Net...

Seeking Alpha | September 9, 2020

Read More 'GLSI' Stories Here

GLSI Price Returns

1-mo 30.05%
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7963 seconds.